A carregar...
Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention
INTRODUCTION: Clopidogrel is commonly prescribed with aspirin to reduce the risk for adverse cardiovascular events after percutaneous coronary intervention (PCI). However, there is significant inter-patient variability in clopidogrel response. The CYP2C19 enzyme is involved in the biotransformation...
Na minha lista:
| Publicado no: | Expert Rev Cardiovasc Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628391/ https://ncbi.nlm.nih.gov/pubmed/28699807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14779072.2017.1355236 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|